References
- CarlssonMWessmanYAlmgrenPGroopL. High levels of nonesterified fatty acids are associated with increased familial risk of cardiovascular diseaseArterioscler Thromb Vasc Biol200020158894
- SuperkoRH. Lipoprotein subclasses and atherosclerosisFront Biosci20016D35565
- TsimikasSWitztumJL. Measuring circulating oxidized low-density lipoprotein to evaluate coronary riskCirculation200110319302
- EharaSUedaMNarukoTHazeKItohAOtsukaM Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromesCirculation200120011955
- CerielloAMotzE. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisitedArterioscler Thromb Vasc Biol20042481623
- VessbyBUusitupaMHermansenKRiccardiGRivelleseAATapsellLC Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: the KANWU studyDiabetologia2001443129
- VessbyBGustafssonI-BTengbladSBobergMAnderssonA. Desaturation and elongation of fatty acids and insulin actionAnn N Y Acad Sci200296718395
- RosellMde FaireUHelléniusM-L. Low prevalence of the metabolic syndrome in wine drinkers – is it the alcohol beverage or the lifestyle?Eur J Clin Nutr20035722734
- SjogrenPRosellMSkoglund-AnderssonCZdravkovicSVessbyBde FaireU Milk-derived fatty acids are associated with a more favourable LDL particle size distribution in healthy menJ Nutr2004134172935
- Skoglund-AnderssonCTangRBondMGde FaireUHamstenAKarpeF. LDL particle size distribution is associated with carotid intima-media thickness in healthy 50-year-old menArterioscler Thromb Vasc Biol199919242230
- TholstrupT. Dairy products and cardiovascular diseaseCurr Opin Lipidol200617110
- AzadbakhtLMirmiranPEsmaillzadehAAziziF. Dairy consumption is inversely associated with the prevalence of the metabolic syndrome in Tehranian adultsAm J Clin Nutr20058252330
- LiuSSongYFordESMansonJEBuringJERidkerPM. Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older US womenDiabetes Care200528292632
- LiuSChoiHKFordESongYKlevakABuringJE A prospective study of dairy intake and the risk of type 2 diabetes in womenDiabetes Care200629127984
- RivelleseAAMaffettoneAVessbyBUusitupaMHermansenKBerglundG Effects of dietary saturated, monounsaturated and n-3 fatty acids on fasting lipoproteins, LDL size and post-prandial lipid metabolism in healthy subjectsAtherosclerosis200316714958
- HodsonLSkeaffCMChisholmW-AH. The effect of replacing dietary saturated fat with polyunsaturated or monounsaturated fat on plasma lipids in free-living young adultsEur J Clin Nutr20015590815
- LindströmJLouherantaAMannelinMRastasMSalminenVErikssenJ The Finnish Diabetes Prevention Study (DPS): lifestyle intervention and 3-year results on diet and physical activityDiabetes Care20032632306
- SjogrenPBasuSRosellMSilveiraAde FaireUVessbyB Measures of oxidized low-density lipoprotein and oxidative stress are not related and not elevated in otherwise healthy men with the metabolic syndromeArterioscler Thromb Vasc Biol20052525806
- BasuS. Isoprostanes: novel bioactive products of lipid peroxidationFree Rad Res20043810522
- SigurdardottirVFagerbergBHultheJ. Circulating oxidized low-density lipoprotein (LDL) is associated with risk factors of the metabolic syndrome and LDL size in clinically healthy 58-year-old men (AIR study)J Intern Med20022524407
- HanselBGiralPNobecourtEChantepieSBruckertEChapmanMJ Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activityJ Clin Endocrinol Metab200489496371
- NälsénCVessbyBBerglundLUusitupaMHermansenKRiccardiG Dietary (n-3) fatty acids reduce plasma F2-isoprostanes but not prostaglandin F2a in healthy humansJ Nutr200613612228
- BasuSHelmerssonJ. Factors regulating isoprostane formation in vivoAntioxid Redox Signal2005722135
- Lopez-GarciaESchulzeMBMansonJEMeigsJBAlbertCMRifaiN Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in womenJ Nutr2004134180611
- NtambiJMMiyazakiM. Recent insights into stearoyl-CoA desaturase-1Curr Opin Lipidol20031425561
- NtambiJMMiyazakiMStoehrJPKendziorskiCMYandellBSSongY Loss of stearoyl-CoA desaturase-1 function protects mice against adiposityProc Natl Acad Sci U S A200299114826
- DobrzynPDobrzynAMiyazakiMCohenPAsilmazEHardieDG Stearoyl-CoA desaturase 1 deficiency increases fatty acid oxidation by activating AMP-activated protein kinase in liverProc Natl Acad Sci U S A2004101640914
- CohenPMiyazakiMSocciNDHagge-GreenbergALiedtkeWSoukasAA Role for stearoyl-CoA desaturase-1 in leptin-mediated weight lossScience20022972403
- BiddingerSBMiyazakiMBoucherJNtambiJMKahnCR. Leptin suppresses stearoyl-CoA desaturase 1 by mechanisms independent of insulin and sterol regulatory element-binding protein-1cDiabetes200655203241
- JiangGQLiZHLiuFEllsworthKDallas-YangQWuM Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1J Clin Invest200511510308
- Gutiérrez-JuárezRPocaiAMulasCOnoHBhanotSMoniaBP Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistanceJ Clin Invest2006116168695
- StumvollM. Control of glycaemia: from molecules to men. Minkowski Lecture 2003Diabetologia20044777081
- AttieADKraussRMGray-KellerMPBrownlieAMiyazakiMKasteleinJJ Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemiaJ Lipid Res2002431899907
- WarensjöEöhrvallMVessbyB. Fatty acid composition and estimated desaturase activities are associated with obesity and lifestyle variables in men and womenNutr Metab Cardiovasc Dis20061612836
- WarensjöERisérusUVessbyB. Fatty acid composition of serum lipids predicts the development of the metabolic syndrome in menDiabetologia20054819992005
- RiserusUTanGDFieldingBANevilleMJCurrieJSavageDB Rosiglitazone increases indexes of stearoyl-CoA desaturase activity in humans – link to insulin sensitization and the role of dominant-negative mutation in peroxisome proliferator-activated receptor-gammaDiabetes200554137984
- Yki-JärvinenH. ThiazolidinedionesN Engl J Med2004351110618
- KusunokiJKanataniAMollerDE. Modulation of fatty acid metabolism as a potential approach to the treatment of obesity and the metabolic syndromeEndocrine20062991100